Hormone replacement therapy and risk for foot, distal forearm, proximal humerus, and pelvis fractures

Theresa H Keegan, Geetha Gopalakrishnan, Stephen Sidney, Charles P. Quesenberry, Jennifer L. Kelsey

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

This case-control epidemiologic study examines the relationship between hormone replacement therapy (HRT) and risk for fractures of four sites among women 45 years of age and older. From October 1996 to May 2001, incident patients with distal forearm (n = 744), foot (n = 618), proximal humerus (n = 331), and pelvis (n = 109) fractures were recruited from five Kaiser Permanente Medical Centers in northern California. Controls (n = 1617) were selected at random from the same five medical centers over the same time period within strata defined by 5-year age group, gender, and white versus nonwhite or unknown recorded race/ethnicity. Trained interviewers collected information using a standardized questionnaire. Compared with postmenopausal women who never used HRT, postmenopausal women currently using HRT for at least 3 months had a decreased risk of fracture at the distal forearm (adjusted OR = 0.55, 95% CI: 0.43, 0.72), proximal humerus (adjusted OR = 0.51, 95% CI: 0.36, 0.74), and pelvis (adjusted OR = 0.51, 95% CI: 0.27, 0.95), but not the foot (adjusted OR = 1.05, 95% CI: 0.81, 1.35). Past use of HRT for more than 7 years also appeared to be associated with a reduced risk off fracture at the distal forearm and proximal humerus. The longer a woman went without HRT after her last menstrual period, the greater her risk of fracture in the distal forearm, proximal humerus, and pelvis. The findings of this study support long-term, current use of HRT for the prevention of osteoporotic fractures, but other risks and benefits also need to be considered.

Original languageEnglish (US)
Pages (from-to)469-475
Number of pages7
JournalOsteoporosis International
Volume14
Issue number6
DOIs
StatePublished - Jul 1 2003
Externally publishedYes

Fingerprint

Humerus
Hormone Replacement Therapy
Pelvis
Forearm
Foot
Osteoporotic Fractures
Estrogen Replacement Therapy
Case-Control Studies
Epidemiologic Studies
Age Groups
Interviews

Keywords

  • Distal forearm fractures
  • Foot fractures
  • Hormone replacement therapy
  • Pelvis fractures
  • Postmenopause
  • Proximal humerus fractures

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hormone replacement therapy and risk for foot, distal forearm, proximal humerus, and pelvis fractures. / Keegan, Theresa H; Gopalakrishnan, Geetha; Sidney, Stephen; Quesenberry, Charles P.; Kelsey, Jennifer L.

In: Osteoporosis International, Vol. 14, No. 6, 01.07.2003, p. 469-475.

Research output: Contribution to journalArticle

Keegan, Theresa H ; Gopalakrishnan, Geetha ; Sidney, Stephen ; Quesenberry, Charles P. ; Kelsey, Jennifer L. / Hormone replacement therapy and risk for foot, distal forearm, proximal humerus, and pelvis fractures. In: Osteoporosis International. 2003 ; Vol. 14, No. 6. pp. 469-475.
@article{d240f3688c604015b4c9a121f4b90ac6,
title = "Hormone replacement therapy and risk for foot, distal forearm, proximal humerus, and pelvis fractures",
abstract = "This case-control epidemiologic study examines the relationship between hormone replacement therapy (HRT) and risk for fractures of four sites among women 45 years of age and older. From October 1996 to May 2001, incident patients with distal forearm (n = 744), foot (n = 618), proximal humerus (n = 331), and pelvis (n = 109) fractures were recruited from five Kaiser Permanente Medical Centers in northern California. Controls (n = 1617) were selected at random from the same five medical centers over the same time period within strata defined by 5-year age group, gender, and white versus nonwhite or unknown recorded race/ethnicity. Trained interviewers collected information using a standardized questionnaire. Compared with postmenopausal women who never used HRT, postmenopausal women currently using HRT for at least 3 months had a decreased risk of fracture at the distal forearm (adjusted OR = 0.55, 95{\%} CI: 0.43, 0.72), proximal humerus (adjusted OR = 0.51, 95{\%} CI: 0.36, 0.74), and pelvis (adjusted OR = 0.51, 95{\%} CI: 0.27, 0.95), but not the foot (adjusted OR = 1.05, 95{\%} CI: 0.81, 1.35). Past use of HRT for more than 7 years also appeared to be associated with a reduced risk off fracture at the distal forearm and proximal humerus. The longer a woman went without HRT after her last menstrual period, the greater her risk of fracture in the distal forearm, proximal humerus, and pelvis. The findings of this study support long-term, current use of HRT for the prevention of osteoporotic fractures, but other risks and benefits also need to be considered.",
keywords = "Distal forearm fractures, Foot fractures, Hormone replacement therapy, Pelvis fractures, Postmenopause, Proximal humerus fractures",
author = "Keegan, {Theresa H} and Geetha Gopalakrishnan and Stephen Sidney and Quesenberry, {Charles P.} and Kelsey, {Jennifer L.}",
year = "2003",
month = "7",
day = "1",
doi = "10.1007/s00198-003-1379-2",
language = "English (US)",
volume = "14",
pages = "469--475",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer London",
number = "6",

}

TY - JOUR

T1 - Hormone replacement therapy and risk for foot, distal forearm, proximal humerus, and pelvis fractures

AU - Keegan, Theresa H

AU - Gopalakrishnan, Geetha

AU - Sidney, Stephen

AU - Quesenberry, Charles P.

AU - Kelsey, Jennifer L.

PY - 2003/7/1

Y1 - 2003/7/1

N2 - This case-control epidemiologic study examines the relationship between hormone replacement therapy (HRT) and risk for fractures of four sites among women 45 years of age and older. From October 1996 to May 2001, incident patients with distal forearm (n = 744), foot (n = 618), proximal humerus (n = 331), and pelvis (n = 109) fractures were recruited from five Kaiser Permanente Medical Centers in northern California. Controls (n = 1617) were selected at random from the same five medical centers over the same time period within strata defined by 5-year age group, gender, and white versus nonwhite or unknown recorded race/ethnicity. Trained interviewers collected information using a standardized questionnaire. Compared with postmenopausal women who never used HRT, postmenopausal women currently using HRT for at least 3 months had a decreased risk of fracture at the distal forearm (adjusted OR = 0.55, 95% CI: 0.43, 0.72), proximal humerus (adjusted OR = 0.51, 95% CI: 0.36, 0.74), and pelvis (adjusted OR = 0.51, 95% CI: 0.27, 0.95), but not the foot (adjusted OR = 1.05, 95% CI: 0.81, 1.35). Past use of HRT for more than 7 years also appeared to be associated with a reduced risk off fracture at the distal forearm and proximal humerus. The longer a woman went without HRT after her last menstrual period, the greater her risk of fracture in the distal forearm, proximal humerus, and pelvis. The findings of this study support long-term, current use of HRT for the prevention of osteoporotic fractures, but other risks and benefits also need to be considered.

AB - This case-control epidemiologic study examines the relationship between hormone replacement therapy (HRT) and risk for fractures of four sites among women 45 years of age and older. From October 1996 to May 2001, incident patients with distal forearm (n = 744), foot (n = 618), proximal humerus (n = 331), and pelvis (n = 109) fractures were recruited from five Kaiser Permanente Medical Centers in northern California. Controls (n = 1617) were selected at random from the same five medical centers over the same time period within strata defined by 5-year age group, gender, and white versus nonwhite or unknown recorded race/ethnicity. Trained interviewers collected information using a standardized questionnaire. Compared with postmenopausal women who never used HRT, postmenopausal women currently using HRT for at least 3 months had a decreased risk of fracture at the distal forearm (adjusted OR = 0.55, 95% CI: 0.43, 0.72), proximal humerus (adjusted OR = 0.51, 95% CI: 0.36, 0.74), and pelvis (adjusted OR = 0.51, 95% CI: 0.27, 0.95), but not the foot (adjusted OR = 1.05, 95% CI: 0.81, 1.35). Past use of HRT for more than 7 years also appeared to be associated with a reduced risk off fracture at the distal forearm and proximal humerus. The longer a woman went without HRT after her last menstrual period, the greater her risk of fracture in the distal forearm, proximal humerus, and pelvis. The findings of this study support long-term, current use of HRT for the prevention of osteoporotic fractures, but other risks and benefits also need to be considered.

KW - Distal forearm fractures

KW - Foot fractures

KW - Hormone replacement therapy

KW - Pelvis fractures

KW - Postmenopause

KW - Proximal humerus fractures

UR - http://www.scopus.com/inward/record.url?scp=0042707570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042707570&partnerID=8YFLogxK

U2 - 10.1007/s00198-003-1379-2

DO - 10.1007/s00198-003-1379-2

M3 - Article

C2 - 12761609

AN - SCOPUS:0042707570

VL - 14

SP - 469

EP - 475

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 6

ER -